Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P54
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -7.73% |
| Q3 2025 | 156.66% |
| Q2 2025 | -5.25% |
| Q1 2025 | -29.03% |
| Q4 2024 | -3.62% |
| Q3 2024 | -10.29% |
| Q2 2024 | -1.64% |
| Q1 2024 | 35.17% |
| Q4 2023 | -16.90% |
| Q3 2023 | -33.30% |
| Q2 2023 | -20.01% |
| Q1 2023 | 135.70% |
| Q4 2022 | -45.49% |
| Q3 2022 | -10.18% |
| Q2 2022 | -33.61% |
| Q1 2022 | 103.71% |
| Q4 2021 | 446.55% |
| Q3 2021 | 61.85% |
| Q2 2021 | -369.03% |
| Q1 2021 | -75.81% |
| Q4 2020 | 92.64% |
| Q3 2020 | -54.44% |
| Q2 2020 | -12.57% |
| Q1 2020 | 656.64% |
| Q4 2019 | -78.79% |
| Q3 2019 | -12.95% |
| Q2 2019 | -35.22% |
| Q1 2019 | 35.71% |
| Q4 2018 | -17.96% |
| Q3 2018 | -16.93% |
| Q2 2018 | 63.78% |
| Q1 2018 | -41.12% |
| Q4 2017 | 1120.51% |
| Q3 2017 | -73.12% |
| Q2 2017 | 0.00% |
| Q1 2017 | -100.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | -100.00% |